✦ LIBER ✦

Clinical Outcome Following Endovascular Therapy for Femoropopliteal Lesion With TASCII Class A and B

✍ Scribed by Kamioka, Norihiko; Soga, Yoshimitsu; Aihara, Hideaki; Tomoi, Yusuke; Murata, Naotaka; Hiramori, Seiichi; Kobayashi, Yohei

Book ID: 123048292
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 72 KB
Volume: 57
Category: Article
ISSN: 1097-6809
DOI: 10.1016/j.jvs.2013.02.119

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

INTRAVASCULAR ULTRASOUND FINDINGS AND TH

INTRAVASCULAR ULTRASOUND FINDINGS AND THE OUTCOMES FOLLOWING ENDOVASCULAR THERAPY WITH A DRUG-ELUTING STENT IN THE FEMOROPOPLITEAL ARTERY

✍ Nanto, Kiyonori; iida, Osamu; Fujita, Masashi; Watanabe, Tetsuya; Awata, Masaki; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 511 KB

Shared and Differential Factors Influenc

Shared and Differential Factors Influencing Restenosis Following Endovascular Therapy Between TASC (Trans-Atlantic Inter-Society Consensus) II Class A to C and D Lesions in the Femoropopliteal Artery

✍ Iida, Osamu; Takahara, Mitsuyoshi; Soga, Yoshimitsu; Suzuki, Kenji; Hirano, Keis 📂 Article 📅 2014 🏛 American College of Cardiology 🌐 English ⚖ 699 KB

Prognostic factors for the clinical outc

Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)

✍ Voso, M T; Martin, S; Hohaus, S; Abdallah, A; Schlenk, R F; Ho, A D; Haas, R 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Investigating the clinical utility of th

Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer

✍ D'Amico, A V; Whittington, R; Malkowicz, S B; Schultz, D; Silver, B; Henry, L; H 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB